Azetidines as histamine H3 receptor antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8912176
SERIAL NO

13147337

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to compounds of formula (I), wherein R, R1, m, n and X1 to X3 have the meaning as cited in the description and the claims. Said compounds are useful as Histamine H3 receptor antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EVOTEC AGESSENER BOGEN 7 HAMBURG 22419

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davenport, Adam James Abingdon Oxfordshire, GB 21 11
Hallett, David James Marlow, GB 24 289
Stimson, Christopher Charles Oxford, GB 7 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 16, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00